Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...

Major changes are coming to the Wilmington International Airport. ILM will be home to a new temperature-controlled ...

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN).

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

One of Chicago's richest dynasties built one of the world’s biggest health-care fortunes over the past century, but these ...

The guidelines took years to finalize, but while regulators were drafting them, a new trend emerged: online pharmaceutical ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...